• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类甲状腺乳头状癌及其淋巴结转移灶中的一种新致癌基因。

A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases.

作者信息

Fusco A, Grieco M, Santoro M, Berlingieri M T, Pilotti S, Pierotti M A, Della Porta G, Vecchio G

出版信息

Nature. 1987;328(6126):170-2. doi: 10.1038/328170a0.

DOI:10.1038/328170a0
PMID:3600795
Abstract

Using DNA transfection analysis on NIH 3T3 cells, activated human oncogenes have been isolated from a variety of fresh solid tumours. Thyroid neoplasias show a wide range of lesions varying from slowly progressive well-differentiated tumours to anaplastic highly malignant neoplasms. Therefore they represent an attractive model to investigate the role of oncogene activation in different stages of the neoplastic state. Here we report the detection of transforming activity in DNAs extracted from five thyroid papillary carcinomas and two of their respective lymph-nodal metastases.

摘要

通过对NIH 3T3细胞进行DNA转染分析,已从多种新鲜实体瘤中分离出活化的人类癌基因。甲状腺肿瘤表现出广泛的病变,从缓慢进展的高分化肿瘤到间变性高恶性肿瘤不等。因此,它们是研究癌基因激活在肿瘤状态不同阶段作用的一个有吸引力的模型。在此,我们报告了从五例甲状腺乳头状癌及其各自的两个淋巴结转移灶中提取的DNA中转化活性的检测结果。

相似文献

1
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases.人类甲状腺乳头状癌及其淋巴结转移灶中的一种新致癌基因。
Nature. 1987;328(6126):170-2. doi: 10.1038/328170a0.
2
Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.在因治疗性放疗引发的人类甲状腺肿瘤中寻找神经营养酪氨酸激酶受体1原癌基因重排。
Br J Cancer. 2000 Jan;82(2):308-14. doi: 10.1054/bjoc.1999.0920.
3
Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.切尔诺贝利核事故暴露儿童的甲状腺乳头状癌中RET原癌基因的致癌重排
Cancer Res. 1995 Dec 1;55(23):5617-20.
4
Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.环磷酸腺苷(cAMP)和丝裂原活化蛋白激酶(MAPK)信号通路在由点突变组成型激活的促甲状腺激素受体(TSHR)基因诱导小鼠3T3成纤维细胞转化中的作用
Oncogene. 2000 Oct 5;19(42):4896-905. doi: 10.1038/sj.onc.1203852.
5
Activated ras oncogenes in human thyroid cancers.
Cancer Res. 1988 Aug 15;48(16):4459-63.
6
Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene.在表达A2a腺苷受体基因和人乳头瘤病毒16型E7癌基因的转基因小鼠中转移性分化型甲状腺癌的早期发生。
Oncogene. 1996 Oct 3;13(7):1471-82.
7
[The role of genetic factors in the pathogenesis of thyroid neoplasms].[遗传因素在甲状腺肿瘤发病机制中的作用]
Postepy Hig Med Dosw. 1997;51(4):367-84.
8
Oncogenes and antioncogenes involved in human thyroid carcinogenesis.参与人类甲状腺癌发生的癌基因和抗癌基因。
J Exp Clin Cancer Res. 1997 Sep;16(3):325-32.
9
Genetic mutations in thyroid carcinoma.甲状腺癌中的基因突变
Minerva Endocrinol. 2009 Mar;34(1):11-28.
10
Thymosin beta-10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro.胸腺素β-10基因过表达与体内外转化甲状腺细胞的高恶性肿瘤表型相关。
Cancer Res. 1998 Feb 15;58(4):823-8.

引用本文的文献

1
Application and recent advances in conventional biomarkers for the prognosis of papillary thyroid carcinoma.传统生物标志物在甲状腺乳头状癌预后评估中的应用及最新进展
Front Oncol. 2025 May 21;15:1598934. doi: 10.3389/fonc.2025.1598934. eCollection 2025.
2
A novel role for nonactin: interfering with G-quadruplex in RET-driven medullary thyroid cancer.诺阿卡菌素的新作用:干扰RET驱动的甲状腺髓样癌中的G-四链体。
BMC Cancer. 2024 Dec 23;24(1):1569. doi: 10.1186/s12885-024-13345-9.
3
Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectives.
分子遗传学、治疗学和 RET 抑制剂耐药性在甲状腺髓样癌中的应用及未来展望。
Cell Commun Signal. 2024 Sep 28;22(1):460. doi: 10.1186/s12964-024-01837-x.
4
DLK1-DIO3 region as a source of tumor suppressor miRNAs in papillary thyroid carcinoma.DLK1-DIO3区域作为甲状腺乳头状癌中肿瘤抑制性微小RNA的来源
Transl Oncol. 2024 Aug;46:101849. doi: 10.1016/j.tranon.2023.101849. Epub 2024 May 31.
5
Harnessing Immunity to Treat Advanced Thyroid Cancer.利用免疫疗法治疗晚期甲状腺癌。
Vaccines (Basel). 2023 Dec 30;12(1):45. doi: 10.3390/vaccines12010045.
6
RET fusion genes in pediatric and adult thyroid carcinomas: cohort characteristics and prognosis.RET 融合基因在儿童和成人甲状腺癌中的作用:队列特征和预后。
Endocr Relat Cancer. 2023 Oct 26;30(12). doi: 10.1530/ERC-23-0117. Print 2023 Dec 1.
7
-Altered Cancers-A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity.- 改变的癌症——肿瘤非特异性生物学、诊断及靶向治疗活性综述
Cancers (Basel). 2023 Aug 17;15(16):4146. doi: 10.3390/cancers15164146.
8
Fusion Oncogenes in Patients With Locally Advanced or Distant Metastatic Differentiated Thyroid Cancer.局部晚期或远处转移性分化型甲状腺癌患者的融合癌基因。
J Clin Endocrinol Metab. 2024 Jan 18;109(2):505-515. doi: 10.1210/clinem/dgad500.
9
Targeting the RET tyrosine kinase in neuroblastoma: A review and application of a novel selective drug design strategy.针对神经母细胞瘤中的 RET 酪氨酸激酶:一种新型选择性药物设计策略的综述与应用。
Biochem Pharmacol. 2023 Oct;216:115751. doi: 10.1016/j.bcp.2023.115751. Epub 2023 Aug 16.
10
Update on Molecular Diagnostics in Thyroid Pathology: A Review.甲状腺病理学中分子诊断的最新进展:综述。
Genes (Basel). 2023 Jun 22;14(7):1314. doi: 10.3390/genes14071314.